The safety and efficacy of endoscopic ultrasound-guided ablation therapy for solid pancreatic tumors: a systematic review

References

• Cheema A, Weber J, Strosberg JR. Incidental detection of pancreatic neuroendocrine tumors: an analysis of incidence and outcomes. Ann Surg Oncol. 2012;19(9):2932–2936.
   PubMed Web of Science ®Google Scholar
• Falconi M, Bartsch DK, Eriksson B, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology. 2012;95(2):120–134.
   PubMed Web of Science ®Google Scholar
• Partelli S, Cirocchi R, Crippa S, et al. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg. 2017;104(1):34–41.
   PubMed Web of Science ®Google Scholar
• Gillen S, Schuster T, Meyer Zum Buschenfelde C, et al. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7(4):e1000267.
   PubMed Web of Science ®Google Scholar
• Dumonceau JM, Polkowski M, Larghi A, et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2011;43(10):897–912.
   PubMed Web of Science ®Google Scholar
• Lee JK, Choi JH, Lee KH, et al. A prospective, comparative trial to optimize sampling techniques in EUS-guided FNA of solid pancreatic masses. Gastrointest Endosc. 2013;77(5):745–751.
   PubMed Web of Science ®Google Scholar
• Lee JK, Lee KT, Choi ER, et al. A prospective, randomized trial comparing 25-gauge and 22-gauge needles for endoscopic ultrasound-guided fine needle aspiration of pancreatic masses. Scand J Gastroenterol. 2013;48(6):752–757.
   PubMed Web of Science ®Google Scholar
• Choi JH, Seo DW, Song TJ, et al. Endoscopic ultrasound-guided radiofrequency ablation for management of benign solid pancreatic tumors. Endoscopy. 2018;50(11):1099–1104.
   PubMed Web of Science ®Google Scholar
• Choi JH, Park DH, Kim MH, et al. Outcomes after endoscopic ultrasound-guided ethanol-lipiodol ablation of small pancreatic neuroendocrine tumors. Dig Endosc. 2018;30(5):652–658.
   PubMed Web of Science ®Google Scholar
• Arcidiacono PG, Carrara S, Reni M, et al. Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer. Gastrointest Endosc. 2012;76(6):1142–1151.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Mohan BP, Shakhatreh M, Garg R, et al. Efficacy and safety of EUS-guided liver biopsy: a systematic review and meta-analysis. Gastrointest Endosc. 2019;89(2):238–246.e3.
   PubMed Web of Science ®Google Scholar
• Paik WH, Seo DW, Dhir V, et al. Safety and efficacy of EUS-guided ethanol ablation for treating small solid pancreatic neoplasm. Medicine (Baltimore). 2016;95(4):1–5.
   Web of Science ®Google Scholar
• Barthet M, Giovannini M, Lesavre N, et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy. 2019;51(9):836–842.
   PubMed Web of Science ®Google Scholar
• Levy MJ, Thompson GB, Topazian MD, et al. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012;75(1):200–206.
   PubMed Web of Science ®Google Scholar
• Park DH, Choi JH, Oh D, et al. Endoscopic ultrasonography-guided ethanol ablation for small pancreatic neuroendocrine tumors: results of a pilot study. Clin Endosc. 2015;48(2):158–164.
   PubMed Web of Science ®Google Scholar
• Song TJ, Seo DW, Lakhtakia S, et al. Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016;83(2):440–443.
   PubMed Web of Science ®Google Scholar
• Qin S, Liu Y, Ning H, et al. EUS-guided lauromacrogol ablation of insulinomas: a novel treatment. Scand J Gastroenterol. 2018;53(5):616–620.
   PubMed Web of Science ®Google Scholar
• Di Matteo FM, Saccomandi P, Martino M, et al. Feasibility of EUS-guided Nd:YAG laser ablation of unresectable pancreatic adenocarcinoma. Gastrointest Endosc. 2018;88(1):168–174.
   PubMed Web of Science ®Google Scholar
• Crinò SF, D'Onofrio M, Bernardoni L, et al. EUS-guided radiofrequency ablation (EUS-RFA) of solid pancreatic neoplasm using an 18-gauge needle electrode: feasibility, safety, and technical success. J Gastrointest Liver Dis. 2018;27(1):67–72.
   PubMed Web of Science ®Google Scholar
• Scopelliti F, Pea A, Conigliaro R, et al. Technique, safety, and feasibility of EUS-guided radiofrequency ablation in unresectable pancreatic cancer. Surg Endosc. 2018;32(9):4022–4028.
   PubMed Web of Science ®Google Scholar
• Oleinikov K, Dancour A, Epshtein J, et al. Endoscopic ultrasound-guided radiofrequency ablation: a new therapeutic approach for pancreatic neuroendocrine tumors. J Clin Endocrinol Metab. 2019;104(7):2637–2647.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Kato H, Horiguchi S, et al. Efficacy and safety of endoscopic ultrasound-guided ethanol ablation therapy for pancreatic neuroendocrine tumors: a prospective pilot study. Acta Med Okayama. 2016;70(4):313–316.
   PubMed Web of Science ®Google Scholar
• Haen SP, Pereira PL, Salih HR, et al. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol. 2011;2011:160250.
   PubMed Web of Science ®Google Scholar
• Waitz R, Solomon SB. Can local radiofrequency ablation of tumors generate systemic immunity against metastatic disease? Radiology. 2009;251(1):1–2.
   PubMed Web of Science ®Google Scholar
• Teng LS, Jin KT, Han N, et al. Radiofrequency ablation, heat shock protein 70 and potential anti-tumor immunity in hepatic and pancreatic cancers: a mini review. Hepatobiliary Pancreat Dis Int. 2010;9:361–365.
   PubMed Web of Science ®Google Scholar
• Dromi SA, Walsh MP, Herby S, et al. Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology. 2009;251(1):58–66.
   PubMed Web of Science ®Google Scholar
• Rovere-Querini P, Manfredi A. Tumor destruction and in situ delivery of antigen presenting cells promote anti-neoplastic immune responses: implications for the immunotherapy of pancreatic cancer. JOP. 2004;5(4):308–314.
   PubMedGoogle Scholar
• Jilesen AP, van Eijck CH, in’t Hof KH, et al. Postoperative complications, in-hospital mortality and 5-year survival after surgical resection for patients with a pancreatic neuroendocrine tumor: a systematic review. World J Surg. 2016;40(3):729–748.
   PubMed Web of Science ®Google Scholar
• Choi JH, Lee SH, Choi YH, et al. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: a single-center experience of 214 patients. Hepatobiliary Pancreat Dis Int. 2019;18(6):562–568.
   PubMed Web of Science ®Google Scholar
• Oh HC, Seo DW, Song TJ, et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140(1):172–179.
   PubMed Web of Science ®Google Scholar
• Park JK, Song BJ, Ryu JK, et al. Clinical outcomes of endoscopic ultrasonography-guided pancreatic cyst ablation. Pancreas. 2016;45:889–894.
   PubMed Web of Science ®Google Scholar